Clinical trial
The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol
NCT00246064 · Centocor Ortho Biotech Services, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00246064 |
|---|---|
| Title | The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol |
| Official title | The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol. Tapering Methotrexate in Patients With Rheumatoid Arthritis Beginning Therapy With Infliximab |
| Lead sponsor | Centocor Ortho Biotech Services, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | infliximab |
| Enrollment | 210 |
| Start date | Dec 1, 2001 |
| Completion | Nov 1, 2003 |
| First posted | Oct 31, 2005 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: